Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia

  1. D Herbert Opi
  2. Olivia Swann  Is a corresponding author
  3. Alexander Macharia
  4. Sophie Uyoga
  5. Gavin Band
  6. Carolyne M Ndila
  7. Ewen Harrison
  8. Mahamadou A Thera
  9. Abdoulaye K Kone
  10. Dapa A Diallo
  11. Ogobara K Doumbo
  12. Kirsten E Lyke
  13. Christopher Plowe
  14. Joann M Moulds
  15. Mohammed Shebbe
  16. Neema Mturi
  17. Norbert Peshu
  18. Kathryn Maitland
  19. Ahmed Raza
  20. Dominic P Kwiatkowski
  21. Kirk A Rockett
  22. Thomas Williams
  23. J Alexandra Rowe
  1. Kenya Medical Research Institute-Wellcome Trust Research Programme, Kenya
  2. University of Edinburgh, United Kingdom
  3. University of Oxford, United Kingdom
  4. University of Bamako, Mali
  5. University of Maryland, United States
  6. Lifeshare Blood Centers, United States

Abstract

Malaria has been a major driving force in the evolution of the human genome. In sub-Saharan African populations, two neighbouring polymorphisms in the Complement Receptor One (CR1) gene, named Sl2 and McCb, occur at high frequencies, consistent with selection by malaria. Previous studies have been inconclusive. Using a large case-control study of severe malaria in Kenyan children and statistical models adjusted for confounders, we estimate the relationship between Sl2 and McCb and malaria phenotypes, and find they have opposing associations. The Sl2 polymorphism is associated with markedly reduced odds of cerebral malaria and death, while the McCb polymorphism is associated with increased odds of cerebral malaria. We also identify an apparent interaction between Sl2 and α+thalassaemia, with the protective association of Sl2 greatest in children with normal α-globin. The complex relationship between these three mutations may explain previous conflicting findings, highlighting the importance of considering genetic interactions in disease-association studies.

Data availability

The following previously published data sets were used
    1. Rockett K
    2. Clarke GM
    3. Fitzpatrick K
    4. Hubbart C
    5. Jeffrys AE
    6. Rowlands K
    7. et al
    (2014) MalariaGEN Consortial Project 1
    Application for access to data: https://www.malariagen.net/data/terms-use/human-gwas-data.

Article and author information

Author details

  1. D Herbert Opi

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  2. Olivia Swann

    Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom
    For correspondence
    Olivia.Swann@ed.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7386-2849
  3. Alexander Macharia

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  4. Sophie Uyoga

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  5. Gavin Band

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Carolyne M Ndila

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  7. Ewen Harrison

    Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Mahamadou A Thera

    Malaria Research and Training Centre, University of Bamako, Bamako, Mali
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2679-035X
  9. Abdoulaye K Kone

    Malaria Research and Training Centre, University of Bamako, Bamako, Mali
    Competing interests
    The authors declare that no competing interests exist.
  10. Dapa A Diallo

    Malaria Research and Training Centre, University of Bamako, Bamako, Mali
    Competing interests
    The authors declare that no competing interests exist.
  11. Ogobara K Doumbo

    Malaria Research and Training Centre, University of Bamako, Bamako, Mali
    Competing interests
    The authors declare that no competing interests exist.
  12. Kirsten E Lyke

    Division of Malaria Research, Institute for Global Health, University of Maryland, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Christopher Plowe

    Division of Malaria Research, Institute for Global Health, University of Maryland, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Joann M Moulds

    Lifeshare Blood Centers, Shreveport, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Mohammed Shebbe

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  16. Neema Mturi

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  17. Norbert Peshu

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  18. Kathryn Maitland

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  19. Ahmed Raza

    Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  20. Dominic P Kwiatkowski

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  21. Kirk A Rockett

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6369-9299
  22. Thomas Williams

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  23. J Alexandra Rowe

    Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7702-1892

Funding

Wellcome Trust (Senior Research Fellowship 091758)

  • Thomas Williams

Wellcome Trust (Senior Research Fellowship202800)

  • Thomas Williams

Wellcome Trust (Senior Research Fellowship084226)

  • J Alexandra Rowe

Wellcome Trust (203077)

  • D Herbert Opi

Wellcome Trust (84538)

  • D Herbert Opi

Wellcome Trust (101910/Z/13/Z)

  • Olivia Swann

Medical Research Council (G19/9)

  • Dominic P Kwiatkowski

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Madhukar Pai, McGill University, Canada

Ethics

Human subjects: This work involved analysing blood samples from patients with malaria and from healthy controls. Written informed consent was obtained from the parents or legal guardians of all participants. The Kenyan studies received ethical approval from the Kenya Medical Research Institute National Ethical Review Committee (approval number SCC1192 for the case-control study and SCC3149 for the longitudinal cohort study), and the Malian studies received ethical approval from the University of Bamako and the University of Maryland (approval number #0899139), and were conducted in accordance with the Declaration of Helsinki.

Version history

  1. Received: August 27, 2017
  2. Accepted: April 1, 2018
  3. Accepted Manuscript published: April 25, 2018 (version 1)
  4. Version of Record published: May 15, 2018 (version 2)

Copyright

© 2018, Opi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,647
    views
  • 210
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. D Herbert Opi
  2. Olivia Swann
  3. Alexander Macharia
  4. Sophie Uyoga
  5. Gavin Band
  6. Carolyne M Ndila
  7. Ewen Harrison
  8. Mahamadou A Thera
  9. Abdoulaye K Kone
  10. Dapa A Diallo
  11. Ogobara K Doumbo
  12. Kirsten E Lyke
  13. Christopher Plowe
  14. Joann M Moulds
  15. Mohammed Shebbe
  16. Neema Mturi
  17. Norbert Peshu
  18. Kathryn Maitland
  19. Ahmed Raza
  20. Dominic P Kwiatkowski
  21. Kirk A Rockett
  22. Thomas Williams
  23. J Alexandra Rowe
(2018)
Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia
eLife 7:e31579.
https://doi.org/10.7554/eLife.31579

Share this article

https://doi.org/10.7554/eLife.31579

Further reading

    1. Epidemiology and Global Health
    Caroline Krag, Maria Saur Svane ... Tinne Laurberg
    Research Article

    Background:

    Comorbidity with type 2 diabetes (T2D) results in worsening of cancer-specific and overall prognosis in colorectal cancer (CRC) patients. The treatment of CRC per se may be diabetogenic. We assessed the impact of different types of surgical cancer resections and oncological treatment on risk of T2D development in CRC patients.

    Methods:

    We developed a population-based cohort study including all Danish CRC patients, who had undergone CRC surgery between 2001 and 2018. Using nationwide register data, we identified and followed patients from date of surgery and until new onset of T2D, death, or end of follow-up.

    Results:

    In total, 46,373 CRC patients were included and divided into six groups according to type of surgical resection: 10,566 Right-No-Chemo (23%), 4645 Right-Chemo (10%), 10,151 Left-No-Chemo (22%), 5257 Left-Chemo (11%), 9618 Rectal-No-Chemo (21%), and 6136 Rectal-Chemo (13%). During 245,466 person-years of follow-up, 2556 patients developed T2D. The incidence rate (IR) of T2D was highest in the Left-Chemo group 11.3 (95% CI: 10.4–12.2) per 1000 person-years and lowest in the Rectal-No-Chemo group 9.6 (95% CI: 8.8–10.4). Between-group unadjusted hazard ratio (HR) of developing T2D was similar and non-significant. In the adjusted analysis, Rectal-No-Chemo was associated with lower T2D risk (HR 0.86 [95% CI 0.75–0.98]) compared to Right-No-Chemo.

    For all six groups, an increased level of body mass index (BMI) resulted in a nearly twofold increased risk of developing T2D.

    Conclusions:

    This study suggests that postoperative T2D screening should be prioritised in CRC survivors with overweight/obesity regardless of type of CRC treatment applied.

    Funding:

    The Novo Nordisk Foundation (NNF17SA0031406); TrygFonden (101390; 20045; 125132).

    1. Epidemiology and Global Health
    Xiaoxin Yu, Roger S Zoh ... David B Allison
    Review Article

    We discuss 12 misperceptions, misstatements, or mistakes concerning the use of covariates in observational or nonrandomized research. Additionally, we offer advice to help investigators, editors, reviewers, and readers make more informed decisions about conducting and interpreting research where the influence of covariates may be at issue. We primarily address misperceptions in the context of statistical management of the covariates through various forms of modeling, although we also emphasize design and model or variable selection. Other approaches to addressing the effects of covariates, including matching, have logical extensions from what we discuss here but are not dwelled upon heavily. The misperceptions, misstatements, or mistakes we discuss include accurate representation of covariates, effects of measurement error, overreliance on covariate categorization, underestimation of power loss when controlling for covariates, misinterpretation of significance in statistical models, and misconceptions about confounding variables, selecting on a collider, and p value interpretations in covariate-inclusive analyses. This condensed overview serves to correct common errors and improve research quality in general and in nutrition research specifically.